News from sangamo biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president, research and...

Jul 29, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast

Sangamo BioSciences, Inc. (NASDAQ: SGMO) today announced that the company will release its second quarter 2015 financial results after the market...

Jun 17, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Presentation At The 2015 JMP Securities Life Sciences Conference

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress...

May 26, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the...

May 18, 2015, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Presents New Data from Proprietary ZFP Therapeutic Programs for Lysosomal Storge Disorders at Annual Meeting of the American Society of Gene and Cell Therapy

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that new data from the company's proprietary ZFP Therapeutic® programs in disease...

May 14, 2015, 09:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Provides Clinical Update On SB-728-T Program and Developments In Other ZFP Therapeutic Programs at American Society of Gene and Cell Therapy Annual Meeting

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that clinical and preclinical data from several ZFP Therapeutic® programs and...

May 13, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Joint Steering Committee Decision To Consolidate ZFP Therapeutic® Strategy For Hemoglobinopathies

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that it will consolidate development paths for the zinc finger nuclease (ZFN)-mediated...

May 12, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Presentation At The UBS 2015 Global Healthcare Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the...

May 07, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Presentation At The Bank Of America Merrill Lynch 2015 Health Care Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the...

Apr 29, 2015, 07:00 ET
Sangamo BioSciences, Inc

Sangamo BioSciences And Collaborators To Present Data On ZFP Therapeutic Applications At Annual Meeting Of The American Society Of Gene And Cell Therapy

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that data from clinical, preclinical and research-stage programs focused on the development...

Apr 22, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Reports First Quarter 2015 Financial Results

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its first quarter 2015 financial results and accomplishments. For the first quarter...

Apr 15, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces First Quarter 2015 Conference Call and Webcast

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) today announced that the company will release its first quarter 2015 financial results after the...

Mar 18, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Participation In The 3rd Annual Regen Med Investor Day Meeting In New York

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Elizabeth Wolffe, Ph.D., Sangamo's vice president, corporate communications,...

Mar 09, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences CEO To Present State Of The Industry Address At Alliance For Regenerative Medicine's Advanced Therapies Summit

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that Edward Lanphier, Sangamo's president and CEO, will present an overview of the state of...

Feb 26, 2015, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed to Provide Functional Control of HIV

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the presentation of new clinical data from its Phase 1/2 clinical trial (SB-728-1101). The...

Feb 25, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Presentation At The Cowen And Company 35th Annual Health Care Conference

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress...

Feb 12, 2015, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Presents Data At 11th Annual WorldSymposium™ Meeting Supporting In Vivo Protein Replacement Platform Approach For The Treatment Of Lysosomal Storage Disorders

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced the presentation of preclinical data from its In Vivo Protein Replacement Platform (IVPRP)...

Feb 10, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Reports Fourth Quarter and Full Year 2014 Financial Results

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its fourth quarter and full year 2014 financial results and accomplishments. For the...

Feb 05, 2015, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Presentation At The 2015 Leerink Global Healthcare Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the...

Feb 04, 2015, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces FDA Acceptance of IND to Initiate Clinical Trial of its Novel ZFP Therapeutic® for Beta-Thalassemia

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that an Investigational New Drug (IND) application for the company's SB-BCLmR-HSPC genome...